Dupont Capital Management Corp Penumbra Inc Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$271.54 - $344.06 $85,263 - $108,034	314 Added 57.93%	856 $294,000
Q1 2023 Apr 28, 2023	BUY	$220.43 - $278.69 $119,473 - $151,049	542 New	542 $151,000
Q3 2020 Oct 29, 2020	SELL	$185.27 - $238.73 $389,067 - $501,333	-2,100 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$153.32 - $191.72 $191,803 - $239,841	1,251 Added 147.35%	2,100 $376,000
Q1 2020 Apr 29, 2020	BUY	$124.34 - $193.76 $105,564 - $164,502	849 New	849 $137,000

370

29.1M

220K

158K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.